Michelle Burke is a Non-Executive Director for Cell Therapies Pty Ltd, past Chair of AusBiotech Ltd, and a current member of the Pharmaceutical Benefits Advisory Committee.  She also serves as an advisor for Proto Axiom Pty Ltd, an incubator for early stage research commercialisation.  She is a consultant to health-related companies, governments and academia, and a former director at Bristol-Myers Squibb and SmithKline Beecham.